GILD · News · 20260901N
Revenue Performance and Dividend
GILEAD SCIENCES, INC. · 2026-09-01 · Importance 47 · Surprise 22 · No source text
Gilead Sciences reported quarterly revenue of $7.80 billion, exceeding analyst expectations. Revenue increased 10.6% year over year. The company declared a quarterly dividend of $0.82 per share.
Key facts
- Gilead Sciences reported revenue growth of 10.6% year-over-year. source
- Gilead Sciences reported quarterly revenue of $7.80 billion. source
- Railway Pension Investments Ltd noted Gilead Sciences reported quarterly revenue of $7.80 billion and declared a quarterly dividend of $0.82 per share. source
- Gilead Sciences announced a quarterly dividend of $0.82 per share. source
- Erste Group Bank adjusted its FY2026 earnings-per-share estimate for Gilead Sciences to a loss of $0.45 per share, from a previous estimate of a $0.75 loss. source
- Railway Pension Investments Ltd sold 7,769 shares of Gilead Sciences and now holds 1.30 million shares valued at $163.7 million. source
- Gilead Sciences reported an adjusted loss of $6.75 per share against a $7.25 consensus estimate for the quarter. source
- Zacks upgraded Gilead to Zacks Rank #1 (Strong Buy). source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | realized | +10.6% | Gilead Sciences reported revenue growth of 10.6% year-over-year. |